Biotechnology - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

76 to 100 of 173 results

HUYA Bioscience partners with Shanghai Zhangjiang Biotech Pharmaceutical Base

06-03-2013

HUYA Bioscience International, jointly headquartered in Shanghai, China, and in San Diego, USA, has entered…

Asia-PacificBiotechnologyHUYA BioscienceLicensingPharmaceuticalResearchShanghai Zhangjiang Biotech

Call for strong Trans-Pacific intellectual property framework from PhRMA

05-03-2013

The Pharmaceutical Research and Manufacturers of America (PhRMA) this week called on nations participating…

Asia-PacificBiotechnologyNorth AmericaPatentsPharmaceuticalSouth America

Japanese approval for Actelion's epoprostenol "ACT"

19-02-2013

Europe's largest biotech firm Actelion (SIX: ATLN) yesterday announced that Japan's Ministry of Health,…

ActelionAsia-PacificBiotechnologyepoprostenol "ACT"RegulationRespiratory and PulmonaryVeletri

Under new govt proposals, Australian R&D tax cut will benefit startups, SMEs

18-02-2013

The Australian government is changing how the R&D Tax Incentive will work so that it will result in tax…

Asia-PacificBiotechnologyFinancialPharmaceuticalResearch

Celgene's Revlimid approved in China for MM; gets PDUFA date in USA for mantle cell lymphoma

12-02-2013

Celgene Corp's (Nasdaq: CELG) European subsidiary revealed that Revlimid (lenalidomide) has been granted…

Asia-PacificBiotechnologyCelgeneNorth AmericaOncologyRegulationRevlimid

EMA and European Commission renew confidentiality arrangement with Japan

07-02-2013

The European Medicines Agency and the European Commission's Directorate General for Health and Consumers…

Asia-PacificBiotechnologyEuropePharmaceuticalRegulation

Australian patients to benefit from Coalition PBS commitment; policies for Bio-Pharma

03-02-2013

The Australian Federal Coalition's election commitment to restoring transparency, certainty and confidence…

Asia-PacificBiotechnologyFinancialPharmaceuticalPoliticsResearch

Indian pharmaceuticals market led by Ranbaxy in terms of revenue

31-01-2013

The Indian pharmaceutical market is the world's third-largest in terms of volume and stands 14th in terms…

Asia-PacificBioconBiotechnologyGenericsMarkets & MarketingPanacea BiotecPharmaceuticalRanbaxy LaboratoriesSerum Institute of India

Kyowa Hakko set to file for pegfilgrastim approval in Japan following strong Ph III data

28-01-2013

Mid-size Japanese drugmaker Kyowa Hakko Kirin (TYO: 4151) on Friday released positive top-line results…

Asia-PacificBiotechnologyKyowa Hakko KirinOncologypegfilgrastimPharmaceuticalRegulationResearch

Australian patent length too short, says AusBiotech submission to Patent Review

24-01-2013

Trade group AusBiotech has made a submission in response to the Australian Pharmaceutical Patents Review's…

Asia-PacificBiotechnologyPatentsPharmaceuticalResearch

China gains WHO designation for biological products center

20-01-2013

China's Institute for Biological Product Control (IBPC) of the National Institutes for Food and Drug…

Asia-PacificBiotechnologyRegulationVaccines

Amgen's Aranesp fails in heart patients; to invest $200 million in Singapore

18-01-2013

USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech firm, announced top-line results…

AmgenAranespAsia-PacificBiotechnologyCardio-vascularProductionResearch

Australia's pharma sector a net importer but also one of its largest high-tech exporters

13-01-2013

The pharmaceutical product manufacturing industry in Australia is dominated by major global pharmaceutical…

Asia-PacificBiotechnologyGenericsMarkets & MarketingPharmaceuticalProduction

Australia's Productivity Commission releases draft report on compulsory licensing of patents

10-01-2013

After reviewing the compulsory licensing provisions in the patents system, Australia's Productivity Commission…

Asia-PacificBiotechnologyPatentsPharmaceutical

Sirtex shines as biotech gears up for big year, says AusBiotech

08-01-2013

As the year commences, Australia's Sirtex Medical is being hailed a stand-out performer for 2012 and…

Asia-PacificBiotechnologyFinancialMesoblastPhosphagenicsSirtex MedicalStarpharma

Bayer files for Japanese approval of Eylea for macular edema following CRVO

07-01-2013

German drug major Bayer(BAYN: DE) says its subsidiary Bayer Yakuhin has applied to the Japanese Ministry…

afliberceptAsia-PacificBayerBiotechnologyEyleaOphthalmicsPharmaceuticalRegeneronRegulationSanten Pharmaceuticals

CEVEC Pharma signs deal with South Korea's Yuhan

20-12-2012

CEVEC Pharmaceuticals, a German developer of a novel human expression system derived from amniocytes,…

Asia-PacificBiotechnologyCEVEC PharmaceuticalsLicensingResearchYuhan Corp

Nexavar use in Chinese patients nearly doubled in 2012

19-12-2012

Use of Nexavar (sorafenib, from Bayer [BAYN: DE] and Onyx Pharmaceuticals) has nearly doubled in first-line…

AlimtaAsia-PacificBayerBiotechnologyEli LillyMarkets & MarketingNexavarOncologyPharmaceutical

Catalent and UMN Pharma collaborate for biosimilars development and production in Japan

16-12-2012

Privately-held USA-based Catalent Pharma Solutions and Japanese drugmaker UMN Pharma (TYO Mothers: 4585)…

Asia-PacificBiotechnologyCatalent Pharma SolutionsGenericsProductionResearchUMN PharmaVaccines

Japan Tobacco files for Japanese approval of elvitegravir

11-12-2012

Japan Tobacco (TSE:2914) has filed a New Drug Application for marketing approval of a novel anti-HIV…

Anti-viralsAsia-PacificBiotechnologyelvitegravirGilead SciencesJapan TobaccoPharmaceuticalRegulationTorii Pharma

Trans Tasman joint therapeutic products scheme progresses

06-12-2012

Progress towards a joint Australia and New Zealand therapeutic products regulatory scheme continued with…

Asia-PacificBiotechnologyPharmaceuticalRegulation

76 to 100 of 173 results

Back to top